Identification | Back Directory | [Name]
RX-3117 | [CAS]
865838-26-2 | [Synonyms]
TV1360 TV-1360 CS-1677 RX-3117 TV 1360 RX-3117 (TV-1360) TV-1360;FLUOROCYCLOPENTENYLCYTOSINE RX-3117; RX3117; RX 3117; TV-1360; TV1360; TV 1360; FLUOROCYCLOPENTENYLCYTOSINE 4-Amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl]-2(1H)-pyrimidinone 2(1H)-Pyrimidinone, 4-amino-1-[(1S,4R,5S)-2-fluoro-4,5-dihydroxy-3-(hydroxymethyl)-2-cyclopenten-1-yl]- | [Molecular Formula]
C10H12FN3O4 | [MDL Number]
MFCD28502078 | [MOL File]
865838-26-2.mol | [Molecular Weight]
257.22 |
Chemical Properties | Back Directory | [Boiling point ]
516.3±60.0 °C(Predicted) | [density ]
1.82±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO:50.0(Max Conc. mg/mL);194.39(Max Conc. mM) | [form ]
Powder | [pka]
12.88±0.70(Predicted) | [color ]
White to off-white |
Hazard Information | Back Directory | [Definition]
ChEBI:Roducitabine is a triol that is (1S,2R)-4-fluoro-3-(hydroxymethyl)cyclopent-3-ene-1,2-diol which is substituted by a 4-amino-2-oxopyrimidin-1(2H)-yl group at position 5. It is a cytidine analog which exhibits anticancer activity in several cancers, including gemcitabine-resistant tumours. It has a role as an antimetabolite, an antineoplastic agent, a prodrug, a DNA synthesis inhibitor and an apoptosis inducer. It is an organofluorine compound, a primary allylic alcohol and a triol. | [storage]
Store at -20°C |
|
Company Name: |
SPIRO PHARMA
|
Tel: |
|
Website: |
www.spiropharma.com.cn |
|